Wyeth and Impax settle litigation over venlafaxine XR
This article was originally published in Scrip
Executive Summary
Wyethand Impax Laboratories said that a federal judge in Delaware approved the conditions of a settlement of US patent infringement litigation relating to a generic version of Wyeth's extended-release venlafaxine product, Effexor XR.